Physician profile
Subhod Rao
NPI 1033303821
$1,044.94
in general payments reported to CMS, 2019-2025
19 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.94 · 2023: $550 · 2024: $220 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $160.61 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $155.33 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $103.41 | 2023-2024 | Breztri, Farxiga |
| Novo Nordisk INC | $83.63 | 2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $76.38 | 2023-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $69.32 | 2022-2023 | |
| Abbvie INC. | $62.97 | 2023-2024 | |
| Glaxosmithkline, LLC. | $52.82 | 2023-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.66 | 2023-2025 | Jardiance, Tradjenta |
| Sanofi-Aventis U.S. LLC | $36.36 | 2023-2025 | |
| Dexcom, INC. | $32.67 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $30.45 | 2023 | Otezla, Repatha |
| Idorsia Pharmaceuticals US INC | $22.74 | 2023 | Quviviq |
| Medtronic, INC. | $22.22 | 2025 | Interstim |
| Astellas Pharma US INC | $22.05 | 2023 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $21.81 | 2024 | Voquezna |
| Sumitomo Pharma America, INC. | $14.49 | 2023 | Gemtesa |
| Seqirus USA INC | $13.66 | 2025 | Fluad, Flucelvax |
| Exact Sciences Corporation | $13.36 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhod Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.